We sincerely welcome Dr. Ramin M. Farahani from Faculty of Medicine and Health, Sydney, Australia, to join the Editorial Board of Advances in Cells. Dr. Peter Kovermann is an outstanding scholar who experts in Mitochondria, Neurogenesis and Notch signalling pathway. We appreciate Dr. Ramin M. Farahani for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

The journal Advances in Cells will have the new APCs (New APC, 500 USD) for manuscripts submitted after 31 December 2024.

Read More Read more about Update: Article Processing Charge (Price Changes Effective January 1, 2025)

We sincerely welcome Dr. Peter Kovermann from Forschungszentrum Jülich GmbH, Julich, Germany, to join the Editorial Board of Advances in Cells. Dr. Peter Kovermann is an outstanding scholar who experts in Neurobiology and Brain Physiology, Neuroscience and Biophysics. We appreciate Dr. Peter Kovermann for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Anu Manhas from Pandit Deendayal Energy University, Gandhinagar, India, to join the Editorial Board of Advances in Cells. The overall aim of her research work is to advance the knowledge of structure-based pharmacophore modeling approach as well as provide useful suggestion for their application in virtual screening. For this purpose, they utilize the knowledge of the pharmacophore modeling to provide an insight about the feature similarity among the selected enzyme classes and share of features among the experimentally reported inhibitors of malaria and tuberculosis. The rationale was to search for the representative pharmacophores and to provide guiding principle for the design of stringent pharmacophore that can be employed for the virtual screening to rationally design new chemical entities that could contribute in treating human diseases. In this regard, they use wide range of methods like multicomplex-based pharmacophore modeling and molecular docking, virtual screening methods like drug-likeness studies and ADMET properties, molecular dynamics simulations and free energy calculations. We appreciate Prof. Dr. Anu Manhas for her participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Belgin Sever from Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey, to join the Editorial Board of Advances in Cells. Prof. Dr. Belgin Sever is currently an Associate Professor, at the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University. Her research mainly focuses on the development of anticancer, antimicrobial, antidiabetic, anti-HIV, and anti-ALS drug candidates in particular based on medicinal chemistry and computational chemistry disciplines. She has published many high-quality articles in prestigious international peer-reviewed journals indexed by Science Citation Index (SCI) and SCI-Expanded. She was awarded the first rank in her graduation from Anadolu University, Faculty of Pharmacy in 2013. She received her MSc and PhD in Pharmaceutical Chemistry from Anadolu University, Faculty of Pharmacy in 2015 and in 2019, respectively. During her PhD, she deserved to be a scholarship holder of The Scientific and Technological Research Council of Turkey (TUBITAK) 2211-A National Scholarship Programme. After her PhD, she was accepted as a fellow of Takeda Science Foundation International Fellowship Program. As a post-doc fellow, she worked at Kumamoto University, Faculty of Life Sciences, Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Kumamoto, Japan from November 2020 to May 2021. She has been also accepted for TUBITAK 2219-International Postdoctoral Research Fellowship Program to work at the same Research Laboratory, Faculty of Life Sciences, Kumamoto University from June 2022 to June 2023. She was selected as a “Young Woman Researcher” in 7th Women Awards - Venus International Women Awards (VIWA) 2022” based on the VIWA 2022 Expert Committee Report and Apex Committee Recommendations. She was also awarded by Turkish Pharmacists' Association- Academy of Pharmacy in 2022 for her contributions to pharmaceutical science. She has been an Editorial Board member of Open Chemistry, Plos One, Heliyon-Pharmaceutical Science, Current Topics in Medicinal Chemistry, Frontiers in Chemistry, Frontiers in Chemical Biology, and Oncology Research. She has been also Guest Editor in Pharmaceuticals, Molecules and Frontiers in Chemistry. We appreciate Prof. Dr. Belgin Sever for her participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Elena Butoi from The Institute of Cellular Biology and Pathology Nicolae Simionescu, Bucharest, Romania, to join the Editorial Board of Advances in Cells. Dr. Elena Butoi currently works as the Group Leader of Biopathology and Therapy of Inflammation. And Dr. Elena Butoi is an outstanding scholar who experts in Atherosclerosis, Inflammation, Cell interactions, Vascular cells and Molecular biology. Dr. Elena Butoi has published 48 publications that have been cited over 1356 times with an H-index of 24. We appreciate Dr. Elena Butoi for her participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Mohamed Zaiou from The University of Lorraine, School of Pharmacy, Vandoeuvre-les-Nancy, France, to join the Editorial Board of Advances in Cells. Mohamed Zaiou currently works at The University of Lorraine, School of medicine/pharmacy. Mohamed does research in the area of Molecular Biology and Cell Biology applied to metabolic diseases. Their most recent publication is 'Epigenetic regulation of genes involved in the reverse cholesterol transport through interaction with miRNAs'. We appreciate Dr. Mohamed Zaiou for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Pietro Di Fazio from Philipps University Marburg, Marburg, Germany, to join the Editorial Board of Advances in Cells. Dr. Pietro Di Fazio is an outstanding scholar who experts in Apoptosis, Cancer research, Epigenetic, Neuroendocrine pancreatic neoplasia and Anaplastic thyroid cancer. Dr. Pietro Di Fazio has published 77 publications that have been cited over 3126 times with an H-index of 26. We appreciate Dr. Pietro Di Fazio for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Navid Kashaninejad from Griffith University, Brisbane, Australia, to join the Editorial Board of Advances in Cells. Dr Navid Kashaninejad received his B.Sc. and M.Sc. degrees in Mechanical Engineering, in 2006 and 2008, respectively. After winning the prestigious SINGA scholarship from the Singapore Agency for Science, Research and Technology (A*STAR), he completed his PhD studies in 2013 under the supervision of Professor Nam-Trung Nguyen at Nanyang Technological University (NTU), Singapore. During his PhD studies, he mainly focused on the design and fabrication of various microfluidic devices and fundamentally investigated the fluid mechanics of flow through microchannels. In particular, he introduced a new parameter, termed eccentricity, that could alter the contact angle and drag reduction capabilities of superhydrophobic microchannels. In 2021, he was awarded the prestigious DECRA fellowship from Australian Research Council (ARC). He also has over two years of experience as a postdoctoral researcher at Griffith University and the University of Technology Sydney. Dr Kashaninejad has demonstrated high-quality multidisciplinary research output in microfluidics, especially in organ-on-a-chip and disease modelling. Currently, he is a full member of Queensland Micro and Nanotechnology Centre (QMNC) and ARC DECRA fellow at Griffith University. We appreciate Dr. Navid Kashaninejad for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Raffaella Comitato from Council for Agricultural Research and Economics-Research Centre for Food and Nutrition, Rome, Italy, to join the Editorial Board of Advances in Cells. Dr. Raffaella Comitato is an outstanding scholar who experts in Polyphenols, Antioxidants, Gene Expression and Oxidative Stress. We appreciate Dr. Raffaella Comitato for her participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Stuart Maudsley from University of Antwerp in Belgium, to join the Editorial Board of Advances in Cells. Prof. Dr. Stuart Maudsley is currently head of the Receptor Biology Lab. The Receptor Biology Lab is a multidisciplinary research division that combines molecular biology, transcriptomic, proteomic and bioinformatics research pipelines to investigate how G protein-coupled receptor (GPCR) systems control the molecular signaling architecture of complex aging-related diseases. Prof. Maudsley is also currently the Co-Founder of the therapeutic start-up HeptOME and additionally consults for the Belgian Government Superior Health Council, several pharmaceutical and venture capital organizations. Prof Maudsley has also served as Vice-Chair of the Department of Biomedical Sciences at the University of Antwerp and as the Adjunct Director of the VIB Department of Molecular Genetics. We appreciate Prof. Dr. Stuart Maudsley for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Kidon Sung from National Center for Toxicological Research, US Food and Drug Administration, United States, to join the Editorial Board of Advances in Cells. Dr. Kidon Sung graduated with a Bachelor of Science and Master of Science in food science and technology from the Kangwon National University, South Korea. Dr. Sung then earned a Ph.D. with a focus on food safety from the University of Georgia. He studied a reverse transcriptase-polymerase chain reaction assay to detect viable Campylobacter jejuni during graduate school. Dr. Sung joined the Division of Microbiology at FDA’s National Center for Toxicological Research (NCTR), as a postdoctoral research fellow and later moved into a research microbiologist staff fellow role. Dr. Sung is a recipient of the Ambassadorial Scholar of International Rotary Club (1998), the Developing Scientist Award of the International Association for Food Protection (2002), the FDA Group Recognition Award (2007), the FDA Excellence in Laboratory Science Group Award (2009, 2015), and the NCTR Special Act Award (2018). We appreciate Prof. Dr. Kidon Sung for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Bingbing Li from Oregon Health & Science University, Portland, United States, to join the Editorial Board of Advances in Cells. Dr. Bingbing Li is interested in the interface between biology and chemistry, using innovative chemical tools to dissect the complexity of cancer biology with the goal of identifying novel cancer therapeutics. In one project, she focuses on the molecular understanding of clear cell sarcoma of soft tissue (CCSST) driven by EWSR1-ATF1/CREB fusion and identification of novel therapeutics for CCSST. The fusion protein EWS-ATF1/CREB is constitutively driving CREB/ATF1-dependent gene transcription. However, EWSR1-ATF1/CREB is predicted to be an intrinsically disordered protein and it is a recalcitrant target for small molecules. To overcome this challenge, she developed and implemented a proteomics screening strategy to identify alternative actionable targets that are critical for EWSR1-ATF1-mediated gene transcription. From this screening, she discovered that protein arginine methyltransferase 5 (PRMT5) is a novel EWSR1-ATF1 binding partner. Using both genetic and chemical methods, she further validated that PRMT5 is a novel druggable vulnerability in CCSST. Specifically, she found that clinical stage PRMT5 inhibitor JNJ-64619178 showed promising anti-CCSST activity in vitro and in vivo. In another project, she is using a combination of chemical biology and cell biology to investigate nuclear lamins. Nuclear lamins are type V nuclear intermediate filament proteins and were thought to be undruggable. She recently discovered the first small molecule called LBL1 that binds to nuclear lamins and uncovered a previously unrecognized role of lamin A in regulating homologous recombination repair of DNA double-strand breaks (DSB).  She capitalizes on this discovery to investigate the nuclear lamina-ome composition under physiologically relevant conditions using LBL1 and its chemical probes. We appreciate Prof. Dr. Bingbing Li for her participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Preedakorn Chunhacha from Chulalongkorn University, Bangkok, Thailand, to join the Editorial Board of Advances in Cells. Prof. Dr. Preedakorn Chunhacha is an outstanding scholar who experts in Cancer Biology, Cancer Metastasis and Cell Proliferation. Prof. Dr. Preedakorn Chunhacha has published 28 publications that have been cited over 558 times with an H-index of 14. We appreciate Prof. Dr. Preedakorn Chunhacha for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Ayenachew Bezawork-Geleta from The University of Melbourne, Australia, to join the Editorial Board of Advances in Cells. Dr. Ayenachew Bezawork-Geleta grew up in Ethiopia and received his MSc in molecular biology from the Hebrew University of Jerusalem (Israel). He did his PhD at La Trobe University and his early postdoctoral research at Griffith University. In 2018 he joined University of Melbourne and is currently working on new regulators of lipid droplet metabolism in health and disease. In recognition of his work, Dr Ayenachew has received competitive awards from International and Australian scientific bodies (e.g. International Union of Biochemistry and Molecular Biology and a fellowship from Pears Foundation of UK). He is highly committed to accelerating access to health through discovery biology while also growing curiosity in the next generation of scientists. We appreciate Dr. Ayenachew Bezawork-Geleta for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Halimeh Hassanpour from Aerospace Research Institute, Tehran, Iran, to join the Editorial Board of Advances in Cells. Prof. Dr. Halimeh Hassanpour is an outstanding scholar who experts in Plant tissue culture and Plant adaptation to abiotic stress. Prof. Dr. Halimeh Hassanpour has published 31 publications that have been cited over 406 times with an H-index of 14. We appreciate Prof. Dr. Halimeh Hassanpour for her participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Barbara Peruzzi from IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, to join the Editorial Board of Advances in Cells. Dr. Barbara Peruzzi is an outstanding scholar who experts in Bone Biology, Bone Regeneration and Cell Culture. Dr. Barbara Peruzzi has published 33 publications that have been cited over 993 times with an H-index of 14. We appreciate Dr. Barbara Peruzzi for her participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Hilal Arnouk from Midwestern University, Downers Grove, United States, to join the Editorial Board of Advances in Cells. Dr. Arnouk received his education and post-doctoral training in the United States at Roswell Park Cancer Institute, the State University of New York at Buffalo, the Medical College of Georgia, and the University of Alabama at Birmingham. He has directed research studies in academia and biotech industry settings. His major areas of expertise include cancer immunotherapy, biomarker discovery, and precision medicine. Additionally, Dr. Arnouk tremendously enjoys being an educator and a mentor for professional students in the medical and biomedical sciences. We appreciate Prof. Dr. Hilal Arnouk for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Juan Sebastian Yakisich from School of Pharmacy, Hampton, United States, to join the Editorial Board of Advances in Cells. Dr. Yakisich is an interdisciplinary biomedical researcher (MD/PhD) with extensive experience in pharmacology, oncology, molecular and cellular biology fostered by a doctoral education at the Karolinska University Hospital, Karolinska Institute (Stockholm, Sweden) and postdoctoral training at the Department of Molecular and Cellular Medicine, Texas A&M University, College Station, TX. He was awarded a very competitive and prestigious research grant by the Swedish Research Council to work as project leader (independent researcher) at the Department of Clinical Neuroscience Karolinska Institute for four additional years. In 2014 Dr. Yakisich joined the Department of Pharmaceutical Sciences at Hampton University where he is currently Assistant Professor. We appreciate Prof. Dr. Juan Sebastian Yakisich for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Mansur Abdullah Sandhu from PMAS-Arid Agriculture University Rawalpindi, Rawalpindi, Pakistan, to join the Editorial Board of Advances in Cells. Prof. Dr. Mansur Abdullah Sandhu is an outstanding scholar who experts in Cell Biology and Mesenchymal Stem Cell. Prof. Dr. Mansur Abdullah Sandhu has published 44 publications that have been cited over 1196 times with an H-index of 15. We appreciate Prof. Dr. Mansur Abdullah Sandhu for his participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member

We sincerely welcome Dr. Antonietta Franco from Washington University School of Medicine in St. Louis, St. Louis, United States, to join the Editorial Board of Advances in Cells. She joined the Dorn laboratory as a transfer graduate student from the University of Naples ~6 years ago, successfully defending her PhD in May 2016 and staying on for post-doctoral training. In July, 2019 she was appointed to the Wash U Research Faculty as she works toward research independence. In collaboration with other DornLab and Wash U collaborators, she has been the lead or co-lead scientist on projects describing allosteric mitofusin activation (Nature 2016), first-in-class small molecule mitofusin activators (Science 2018), and organ-specific pathological effects of different natural human MFN2 mutations using cell and genetic mouse models (eLife 2020 and submitted). Her principal effort now is functionally dissecting the consequences of disrupted mitofusin-mediated fusion vs mitophagy in cardiomyopathy. We appreciate Dr. Antonietta Franco for her participation and support.

Read More Read more about Advance in Cells Welcomes New Editorial Board Member